Live Breaking News & Updates on Maple fung

Stay informed with the latest breaking news from Maple fung on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Maple fung and stay connected to the pulse of your community

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Australia , New-zealand , Maple-fung , Ono-pharmaceutical-co-ltd , Medicines-partnership , Equillium-inc , European-league-against-rheumatism , Biocon , European-renal-association , Lupus-network , Nasdaq , Ono-pharmaceutical

Equillium delivers new lupus data to Ono's doorstep

Equillium delivers new lupus data to Ono's doorstep
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

India , Maple-fung , Ono-pharmaceuticals , Biocon , Ono-pharmaceuticals- , Aurinia-pharmaceutical , Medical-officer-maple-fung ,

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Kenneth-kalunian , Maple-fung , Michael-moore , American-college-of-rheumatology , Ono-pharmaceutical-co-ltd , Lupus-network , Investor-relations-corporate-communications , Equillium-inc , Nasdaq , Medicines-partnership , School-of-medicine , Exchange-commission

Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

$48.4 million in cash at the end of Q2 2023 expected to provide operating runway into 2025Fully prepaid and retired debt facilityAuthorized $7.5 million stock repurchase programLA JOLLA, Calif.--(BUSINESS WIRE)--$EQ--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding...

Japan , United-states , Australia , American , Japanese , Australian , Michael-moore , Maple-fung , Head-of-corporate-communications , American-association-of-immunologists , Clinical-development , Nasdaq

Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India

Biocon Limited initiates clinical study of Itolizumab for Ulcerative Colitis in India
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

India , Maple-fung , Siddharth-mittal , Sandeep-athalye , Biocon-biologics , Equillium-inc , Biocon , Clinical-development , Biocon-limited , Ulcerative-colitis , Drugs-controller-general , Managing-director

Equillium Announces Data Suggesting Soluble ALCAM as a Potential Biomarker of Disease Severity in Lupus Nephritis at ACR Convergence 2022

Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced... | November 14, 2022

Pennsylvania , United-states , Philadelphia , Dalena-chu , Maple-fung , Biocon , Equillium-inc , American-college-of-rheumatology , Pennsylvania-convention-center , Nasdaq , American-college , Strong-predictor